INT288820

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.68
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 3.93
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endoplasmic reticulum (Rasgrf2) plasma membrane (Rasgrf2) intracellular (Rasgrf2)
cytoplasm (Rasgrf2)
Rasgrf2 (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 4 5.00 Very Low Very Low Very Low
Pain 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Lymphatic System Cancer 176 99.00 Very High Very High Very High
Htlv Types I And Ii 4 96.12 Very High Very High Very High
Chronic Lymphoid Leukemia 16 94.76 High High
Cancer 260 93.72 High High
Multiple Myeloma 4 89.40 High High
Leukemia 84 81.28 Quite High
Hematologic Neoplasms 4 61.28 Quite High
Sprains And Strains 20 52.72 Quite High
Targeted Disruption 4 50.00 Quite Low
Lymphadenopathy 8 24.40 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Instead, we detected a reduction in RASGRF2 transcript levels in 81% of all the human lymphoma cases analyzed (Figure 5, lower panel).
Transcription (levels) of RASGRF2 associated with lymphatic system cancer
1) Confidence 0.68 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 1.00 Pain Relevance 0
No statistically significant upregulated levels of the RASGRF2 mRNA were observed in these samples (Figure 5, lower panel).
Transcription (observed) of RASGRF2
2) Confidence 0.53 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 0.92 Pain Relevance 0
No statistically significant upregulated levels of the RASGRF2 mRNA were observed in these samples (Figure 5, lower panel).
Transcription (levels) of RASGRF2
3) Confidence 0.53 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 0.88 Pain Relevance 0
In contrast to the RT–PCR data, we found no significant variations in the expression levels of the RASGRF2 mRNA in the microarray data available at the Oncomine site, indicating that this gene is not commonly deregulated at least in the case of the hematopoietic tumors selected in this study.
Transcription (levels) of RASGRF2 associated with cancer
4) Confidence 0.53 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 1.13 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox